Luis E. Raez, MD, FACP, FCCP; is the President of the Florida Society of Clinical Oncology (FLASCO). He works as Chief of Hematology/Oncology & Medical Director of Memorial Cancer Institute (MCI), he is also Director of the Thoracic Oncology Program. He is Co-Director of the MCI/FAU Florida Cancer Center of Excellence designated by the Florida governor, one of the five cancer centers in Florida. He is also Clinical Professor of Medicine at Florida International University (FIU) and Visiting Professor of Medicine at Cayetano Heredia University in Peru. He is also an Affiliate Associate Professor of Clinical Biomedical Science for Florida Atlantic University (FAU).
He was an Associate Professor of Medicine, Epidemiology and Public Health, and a Co-Director of Thoracic Oncology at Sylvester Cancer Center/University of Miami for 10 years (2001-2011). He has expertise in medical oncology in the areas of lung cancer, and head and neck cancer.
He designs phase I-III clinical trials with new chemotherapeutic agents and combinations. Dr. Raez does translational research and clinical research. He has been funded by NCI and the pharma industry. He has given oral presentations and lectures in national and international meetings in the US, Europe, Latin-America, Africa and Asia.
He has been the Chairman of the IASLC Latin American Group (LATAM) since 2018; Chair of the IASLC Membership Committee from 2015-2018; International Chair of the IASLC-Latin-American Meeting (LALCA) since 2014; Chairman for the "Miami Best of ASCO" since 2014, Chair and Founder of the "Miami Cancer Meeting (MCM)" since 2002, Co-Chairman at the "Puerto Rico Fall Cancer Symposia (FCS)" since 2010. He is one of the founder members of Oncology Latin-American Association (OLA).
He is American Board Certified in: Internal Medicine and Medical Oncology. He is board eligible in Hematology.
He is a member and serves in several committees at: AACR, OLA, ESMO, ASCO, IASLC, ALLIANCE, NCCTG, ACCP, ACP, ACSG, SLACOM, FLASCO among other institutions.